Baird analyst Robert Mason raised the firm’s price target on Novanta (NOVT) to $150 from $138 and keeps a Neutral rating on the shares. The firm updated its model following Q4 results which suggests the company is positioned for accelerating sales and margins.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOVT: